BALLYLAGAN LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Ballylagan Limited. The company was founded 5 years ago and was given the registration number NI659554. The firm's registered office is in BELFAST. You can find them at 11 Kensington Crescent, , Belfast, Co. Antrim. This company's SIC code is 74909 - Other professional, scientific and technical activities n.e.c..

Company Information

Name	:	BALLYLAGAN LIMITED
Company Number	:	NI659554
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active
Incorporation Date	:	06 March 2019
End of financial year	:	31 March 2023
Jurisdiction	:	Northern - Ireland
Industry Codes	:	74909 - Other professional, scientific and technical activities n.e.c. 85590 - Other education n.e.c. 86210 - General medical practice activities

Office Address & Contact

Registered Address	:	11 Kensington Crescent, Belfast, Co. Antrim, United Kingdom, BT5 6BL
Country Origin	:	UNITED KINGDOM
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

Company Officers

Personal Information	Role	Appointed	Status
13, Malone Ridge, Malone, Belfast, Northern Ireland, BT9 5QW	Secretary	06 March 2019	Active
13, Malone Ridge, Malone, Belfast, Northern Ireland, BT9 5QW	Director	06 March 2019	Active

People with Significant Control

Dr Maeve Lagan
Notified on	:	06 March 2019
Status	:	Active
Date of birth	:	May 1978
Nationality	:	Irish
Country of residence	:	Northern Ireland
Address	:	13, Malone Ridge, Belfast, Northern Ireland, BT9 5QW
Nature of control	:	Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (1 year ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (3 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (11 months ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (1 months remaining)